about
Identification of genes involved in Ca2+ ionophore A23187-mediated apoptosis and demonstration of a high susceptibility for transcriptional repression of cell cycle genes in B lymphoblasts from a patient with Scott syndromePlatelet lipidomics: modern day perspective on lipid discovery and characterization in plateletsIgE receptor type I-dependent tyrosine phosphorylation of phospholipid scramblaseTMEM16F forms a Ca2+-activated cation channel required for lipid scrambling in platelets during blood coagulationInherited platelet disorders: a clinical approach to diagnosis and management.Clinical characterization of canine platelet procoagulant deficiency (Scott syndrome).Phospholipid-esterified eicosanoids are generated in agonist-activated human platelets and enhance tissue factor-dependent thrombin generation.Role of flippases, scramblases and transfer proteins in phosphatidylserine subcellular distributionRole of shear rate and platelets in promoting fibrin formation on rabbit subendothelium. Studies utilizing patients with quantitative and qualitative platelet defects.Scott syndrome: an inherited defect of the procoagulant activity of platelets.Historical perspective and future directions in platelet research.Protection of factor Xa from neutralization by the heparin-antithrombin complex.Aspirin: pharmacology and clinical applicationsBiological properties of extracellular vesicles and their physiological functions.TMEM16F is required for phosphatidylserine exposure and microparticle release in activated mouse platelets.Platelet receptor-mediated factor X activation by factor IXa. High-affinity factor IXa receptors induced by factor VIII are deficient on platelets in Scott syndrome.Production and characterization of transformed B-lymphocytes expressing the membrane defect of Scott syndrome.The how and why of exocytic vesicles.A review of inherited platelet disorders with guidelines for their management on behalf of the UKHCDO.Microparticles and exosomes: impact on normal and complicated pregnancy.R93W mutation in Orai1 causes impaired calcium influx in platelets.Scott syndrome erythrocytes contain a membrane protein capable of mediating Ca2+-dependent transbilayer migration of membrane phospholipidsExclusion of ABCA-1 as a candidate gene for canine Scott syndrome.Scramblase TMEM16F terminates T cell receptor signaling to restrict T cell exhaustion.The ins and outs of phospholipid asymmetry in the plasma membrane: roles in health and disease.Phospholipid scramblase: an update.Microparticles: a critical component in the nexus between inflammation, immunity, and thrombosis.Platelet membrane phospholipid asymmetry: from the characterization of a scramblase activity to the identification of an essential protein mutated in Scott syndrome.Arterial thrombosis--insidious, unpredictable and deadly.Platelet signaling-a primer.Congenital defects of platelet function.Platelet microvesicles in health and disease.Disorders of platelet function: mechanisms, diagnosis and management.Regulation of platelet-fibrin thrombi on subendothelium.Regulation of phospholipid asymmetry and induction of antiphospholipid antibodies.Physiology of membrane lipid asymmetry.Binding of thrombin-activated human factor VIII to platelets.Inhibition of protease-activated receptor 4 impairs platelet procoagulant activity during thrombus formation in human blood.Impaired redistribution of aminophospholipids with distinctive cell shape change during Ca2+-induced activation of platelets from a patient with Scott syndrome.
P2860
Q24811364-213F690D-E8CB-4B3E-A649-3D070D9931F1Q26998976-E7BDED6C-F8BA-4C59-9113-5FEFEB2FE571Q28565124-C6FAFBD1-3C65-4DC1-AC78-4F47D057480DQ28590146-BB796EAE-5C0C-419C-976E-B3536FF095C7Q33396427-FEB12A26-C5F3-459D-81F8-D4DD9304B493Q33403778-F21B09FB-29C7-468C-AE0A-99A5D710FDECQ33747915-BE4F17C8-F101-4D10-A315-F4AE15CD7DDFQ34441896-0F611C2C-4D86-4726-A572-4EF037AC0186Q34543503-48715819-6309-408C-BD03-F181614F010EQ34617911-C63DAB95-DC99-4A65-833D-BC81E10CC00DQ35185593-905C753E-2DAF-4341-B3A3-D46885760CBBQ35207027-B8EF0FF4-7F66-4BE0-B2AA-283E95F620B0Q35608778-6D3EC693-2CBD-48D2-B348-579C29961ED0Q35611763-218593CD-65BA-4E51-A23F-BAC2FAC6190FQ35791236-9EEFEE33-4356-4518-8CF1-D2D2AE33BF95Q35814182-4C494B78-EF7A-4E74-BB32-8A7B270BC046Q35824436-E5607095-50D1-41D3-8483-E70F03E5A941Q36362785-6EF82B82-1DB0-4A63-9808-5130C0C4C465Q36654370-385D4EB3-5E08-4DB8-94FE-D857E942C141Q36964906-8D30C286-4273-4107-A02B-4D73F2957735Q37066268-B7A607E4-7EE1-4425-9062-CEE2BDF7AB23Q37366771-1F20E8D6-4C51-4A0D-BBB9-35872B0900EDQ37398641-7EE8633E-B3D5-4809-A3F9-8AB2E333A7E5Q37415243-B7C8BDFF-A429-483F-AE81-0815E3516249Q37455021-47C791C9-EDB1-449F-83BE-30BAF5A52FD6Q37715024-F121333C-3A58-4AF2-956F-2F8886632EC9Q37922118-21D44625-61A1-47C9-ACB4-7A8DCC8159FDQ37940636-E47CB7A9-DBA7-45D7-9236-3E9DF40520EEQ37953778-DC173AC9-BC82-4C86-94BE-24EEE96CDF4AQ37982455-3AE5262C-D560-48A5-998A-B3BD5C5DD153Q38047367-7B50CAB3-DEE9-490A-9226-998614B23854Q39094993-00BBFA1F-45D3-41BD-A578-32BA79F482F3Q39345812-114C4CC4-C7D0-446E-98E4-1D20A32BCF68Q39695061-B3B4BFE2-0BAB-4250-A2E5-D7B5CBA1837AQ40529756-72391117-4B41-408F-8698-2D47CBE52DCAQ40558482-F20783CC-00C1-41FF-884A-ACFB42E18D6CQ45887060-C3AF0AF0-47D2-46E0-B46A-2FCF24AD2933Q51522575-35DFB7DC-4DDC-48B0-854B-CA3ABAB2BE3AQ52530598-AAF47572-9637-4969-A8FD-5B1DDBB9F11E
P2860
description
1979 nî lūn-bûn
@nan
1979 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1979 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1979年の論文
@ja
1979年論文
@yue
1979年論文
@zh-hant
1979年論文
@zh-hk
1979年論文
@zh-mo
1979年論文
@zh-tw
1979年论文
@wuu
name
Isolated deficiency of platelet procoagulant activity.
@ast
Isolated deficiency of platelet procoagulant activity.
@en
Isolated deficiency of platelet procoagulant activity.
@nl
type
label
Isolated deficiency of platelet procoagulant activity.
@ast
Isolated deficiency of platelet procoagulant activity.
@en
Isolated deficiency of platelet procoagulant activity.
@nl
prefLabel
Isolated deficiency of platelet procoagulant activity.
@ast
Isolated deficiency of platelet procoagulant activity.
@en
Isolated deficiency of platelet procoagulant activity.
@nl
P2093
P1476
Isolated deficiency of platelet procoagulant activity.
@en
P2093
P304
P356
10.1016/0002-9343(79)90392-9
P407
P577
1979-08-01T00:00:00Z